$cvm 2021 Q1 10-Q

Concept	2021 Q1	2020 Q3	2020 Q1
Revenue	$0.00	$28.56K	$298.7K
YoY Change	-100.0%	-62.73%	98.14%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.311M	$3.314M	$2.559M
YoY Change	29.43%	225.67%	32.43%
% of Gross Profit
Research & Development	$5.222M	$5.328M	$4.459M
YoY Change	17.11%	13.3%	76.54%
% of Gross Profit
Depreciation & Amortization	$550.8K	$548.9K	$561.7K
YoY Change	-1.94%	355.49%	248.31%
% of Gross Profit
Operating Expenses	$8.533M	$8.642M	$7.017M
YoY Change	21.6%	51.07%	57.43%
Operating Profit	-$8.533M		-$6.718M
YoY Change	27.01%
Interest Expense	-$3.302M	$2.952M	-$3.302M
YoY Change	-0.02%	39.99%	131.19%
% of Operating Profit
Other Income/Expense, Net	$553.6K	$113.4K	$953.0K
YoY Change	-41.9%	-108.63%	-233.73%
Pretax Income	-$11.28M	-$5.548M	-$9.068M
YoY Change	24.41%	14.43%	40.64%
Income Tax
% Of Pretax Income
Net Earnings	-$11.28M	-$5.548M	-$9.068M
YoY Change	24.41%	14.43%	40.64%
Net Earnings / Revenue		-19424.68%	-3035.46%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.28	-$144.7K	-$250.7K
COMMON SHARES
Basic Shares Outstanding	40.05M shares		36.17M shares
Diluted Shares Outstanding

Concept	2021 Q1	2020 Q3	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.58M	$15.51M	$14.33M
YoY Change	22.7%	83.65%	159.88%
Cash & Equivalents	$6.431M	$15.51M	$14.33M
Short-Term Investments	$11.15M
Other Short-Term Assets	$770.2K	$1.313M	$565.3K
YoY Change	36.26%	150.2%	58.8%
Inventory	$1.459M	$820.1K	$849.6K
Prepaid Expenses		$1.313M
Receivables	$54.92K	$54.92K	$62.29K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$19.87M	$17.70M	$15.81M
YoY Change	25.68%	80.31%	134.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.60M	$5.844M	$18.86M
YoY Change	-33.18%	-63.07%	17.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.671M	$1.671M	$1.671M
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$1.700M	$1.700M	$20.84M
YoY Change	-91.84%	-90.45%	15.77%
TOTAL ASSETS
Total Short-Term Assets	$19.87M	$17.70M	$15.81M
Total Long-Term Assets	$1.700M	$1.700M	$20.84M
Total Assets	$48.37M	$40.54M	$36.65M
YoY Change	31.98%	46.75%	48.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.391M	$2.023M	$1.140M
YoY Change	109.78%	27.52%	-72.59%
Accrued Expenses	$519.1K	$510.5K	$1.070M
YoY Change	-51.47%	-31.37%	-17.6%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$900.0K	$900.0K
YoY Change
Total Short-Term Liabilities	$5.823M	$4.266M	$5.271M
YoY Change	10.46%	41.25%	-3.64%
LONG-TERM LIABILITIES
Long-Term Debt	$12.05M	$11.75M	$12.23M
YoY Change	-1.45%	-12.99%	-9.01%
Other Long-Term Liabilities	$125.0K	$125.0K	$5.005M
YoY Change	-97.5%	-15.28%	2.46%
Total Long-Term Liabilities	$125.0K	$125.0K	$17.24M
YoY Change	-99.27%	-15.28%	-5.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.823M	$4.266M	$5.271M
Total Long-Term Liabilities	$125.0K	$125.0K	$17.24M
Total Liabilities	$19.03M	$20.81M	$22.51M
YoY Change	-15.44%	-7.47%	-5.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$401.1M	-$381.8M
YoY Change		7.95%
Common Stock	$408.2K	$387.3K
YoY Change		9.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$29.33M	$19.73M	$14.14M
YoY Change
Total Liabilities & Shareholders Equity	$48.37M	$40.54M	$36.65M
YoY Change	31.98%	46.75%	48.04%

Concept	2021 Q1	2020 Q3	2020 Q1
OPERATING ACTIVITIES
Net Income	-$11.28M	-$5.548M	-$9.068M
YoY Change	24.41%	14.43%	40.64%
Depreciation, Depletion And Amortization	$550.8K	$548.9K	$561.7K
YoY Change	-1.94%	355.49%	248.31%
Cash From Operating Activities	-$4.957M	-$3.586M	-$3.889M
YoY Change	27.47%	-7.74%	7.05%
INVESTING ACTIVITIES
Capital Expenditures	-$3.479M	-$1.125M	-$652.6K
YoY Change	433.15%	17308.36%	321.59%
Acquisitions
YoY Change
Other Investing Activities	-$11.15M
YoY Change
Cash From Investing Activities	-$14.62M	-$1.125M	-$657.1K
YoY Change	2125.74%	2193.19%	320.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.152M	82.89K	9.492M
YoY Change	-56.25%	-97.14%	262.19%
NET CHANGE
Cash From Operating Activities	-4.957M	-3.586M	-3.889M
Cash From Investing Activities	-14.62M	-1.125M	-657.1K
Cash From Financing Activities	4.152M	82.89K	9.492M
Net Change In Cash	-15.43M	-4.628M	4.947M
YoY Change	-411.92%	344.68%	-523.43%
FREE CASH FLOW
Cash From Operating Activities	-$4.957M	-$3.586M	-$3.889M
Capital Expenditures	-$3.479M	-$1.125M	-$652.6K
Free Cash Flow	-$1.477M	-$2.462M	-$3.236M
YoY Change	-54.35%	-36.57%	-6.95%

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.49
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.41
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40906593	shares
CY2020Q3	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	54922	USD
CY2020Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1313432	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	1458823	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	820052	USD
CY2021Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	48210	USD
CY2020Q3	us-gaap	Deposit Assets DepositAssets	1670917	USD
CY2021Q1	us-gaap	Assets Assets	48365171	USD
CY2020Q3	us-gaap	Assets Assets	40536454	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2391316	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2023067	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	519071	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	510515	USD
CY2020Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	0	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	19866689	USD
CY2021Q1	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	457105	USD
CY2020Q3	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	448022	USD
CY2021Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2282609	USD
CY2020Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213787	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	17697315	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	12814612	USD
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	13811849	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1121029	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1198958	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12599492	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5843993	USD
CY2021Q1	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	292432	USD
CY2020Q3	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	313422	USD
CY2021Q1	us-gaap	Deposit Assets DepositAssets	1670917	USD
CY2021Q1	cvm	Lease Liabilities Current Portion LeaseLiabilitiesCurrentPortion	172454	USD
CY2020Q3	cvm	Lease Liabilities Current Portion LeaseLiabilitiesCurrentPortion	1070123	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5822555	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4265514	USD
CY2021Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2020Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3551826	USD
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	12054543	USD
CY2020Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	11753100	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1031281	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1114340	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	125000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	125000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	19033379	USD
CY2020Q3	us-gaap	Liabilities Liabilities	20809780	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40823975	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38730150	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	408240	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	387302	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	429976839	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	401174675	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-401053287	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-381835303	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	29331792	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	19726674	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48365171	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40536454	USD
	us-gaap	Other Income OtherIncome	0	USD
	us-gaap	Other Income OtherIncome	334232	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10636274	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8711360	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6627640	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5197418	USD
	us-gaap	Operating Expenses OperatingExpenses	17263914	USD
	us-gaap	Operating Expenses OperatingExpenses	13908778	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17263914	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13574546	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	36896	USD
	cvm	Gain Loss On Derivatives Instruments GainLossOnDerivativesInstruments	-2108181	USD
	cvm	Gain Loss On Derivatives Instruments GainLossOnDerivativesInstruments	-2282518	USD
	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	675236	USD
	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	1725180	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-504190	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19217984	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14599178	USD
	cvm	Modification Of Warrants ModificationOfWarrants	-85779	USD
	cvm	Modification Of Warrants ModificationOfWarrants	-21734	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19303763	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14620912	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39351194	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	35621711	shares
CY2021Q1	us-gaap	Other Income OtherIncome	0	USD
CY2020Q1	us-gaap	Other Income OtherIncome	298726	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5221514	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4458547	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3311484	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2558522	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	8532998	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	7017069	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8532998	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6718343	USD
CY2021Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2020Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	18448	USD
CY2021Q1	cvm	Gain Loss On Derivatives Instruments GainLossOnDerivativesInstruments	-3041017	USD
CY2020Q1	cvm	Gain Loss On Derivatives Instruments GainLossOnDerivativesInstruments	-3049027	USD
CY2021Q1	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	553630	USD
CY2020Q1	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	934511	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-260735	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-253407	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11281120	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9067818	USD
CY2021Q1	cvm	Modification Of Warrants ModificationOfWarrants	0	USD
CY2020Q1	cvm	Modification Of Warrants ModificationOfWarrants	-21734	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11281120	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9089552	USD
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40047273	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	36165050	shares
CY2020Q4	cvm	Proceeds From The Sale Of Common Stock Amount ProceedsFromTheSaleOfCommonStockAmount	13559500	USD
CY2020Q4	cvm	Warrant Exercises Amount WarrantExercisesAmount	89250	USD
CY2020Q4	cvm	Equity Based Compensation Employees Amount EquityBasedCompensationEmployeesAmount	3296309	USD
CY2020Q4	cvm	Contributionspai Incommonstock Amount ContributionspaiIncommonstockAmount	41671	USD
CY2020Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	152450	USD
CY2020Q4	cvm	Options Exercises Amount OptionsExercisesAmount	23511	USD
CY2020Q4	cvm	Modification Of Warrants Amount ModificationOfWarrantsAmount	192	USD
CY2020Q4	cvm	Share Issuance Costs ShareIssuanceCosts	-117021	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-7936864	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	28835672	USD
CY2021Q1	cvm	Warrant Exercises Amount WarrantExercisesAmount	7938841	USD
CY2021Q1	cvm	Equity Based Compensation Employees Amount EquityBasedCompensationEmployeesAmount	3282742	USD
CY2021Q1	cvm	Contributions Paid In Common Stock Amount ContributionsPaidInCommonStockAmount	51420	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	379277	USD
CY2021Q1	cvm	Options Exercises Amount OptionsExercisesAmount	138788	USD
CY2021Q1	cvm	Share Issuance Costs ShareIssuanceCosts	-13828	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-11281120	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	29331792	USD
CY2019Q4	cvm	Adoption Of New Accounting Standard AdoptionOfNewAccountingStandard	2146195	USD
CY2019Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5050003	USD
CY2019Q4	cvm	Warrant Exercises Amount WarrantExercisesAmount	297101	USD
CY2019Q4	cvm	Equity Based Compensation Employees Amount EquityBasedCompensationEmployeesAmount	1800225	USD
CY2019Q4	cvm	Contributions Paid In Common Stock Amount ContributionsPaidInCommonStockAmount	40937	USD
	cvm	Short Term Investment ShortTermInvestment	5728	USD
	cvm	Short Term Investment ShortTermInvestment	0	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	5133667	USD
CY2019Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	84447	USD
CY2019Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	25000	USD
CY2019Q4	cvm	Share Issuance Costs ShareIssuanceCosts	-92150	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-5531360	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	8954065	USD
CY2020Q1	cvm	Proceeds From The Sale Of Common Stock Amount ProceedsFromTheSaleOfCommonStockAmount	7867629	USD
CY2020Q1	cvm	Warrant Exercises Amount WarrantExercisesAmount	4318706	USD
CY2020Q1	cvm	Equity Based Compensation Employees Amount EquityBasedCompensationEmployeesAmount	1780979	USD
CY2020Q1	cvm	Contributions Paid In Common Stock Amount ContributionsPaidInCommonStockAmount	38959	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	235024	USD
CY2020Q1	cvm	Purchase Of Stock By Officers And Directors Amount PurchaseOfStockByOfficersAndDirectorsAmount	159990	USD
CY2020Q1	cvm	Options Exercises Amount OptionsExercisesAmount	49898	USD
CY2020Q1	cvm	Share Issuance Costs ShareIssuanceCosts	-199372	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-9067818	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	14138060	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19217984	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14599178	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1101477	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1064231	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	552664	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	347227	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6579051	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3581204	USD
	cvm	Common Stock Contributed To Employee Benefit Plan CommonStockContributedToEmployeeBenefitPlan	93091	USD
	cvm	Common Stock Contributed To Employee Benefit Plan CommonStockContributedToEmployeeBenefitPlan	79896	USD
	cvm	Loss On Derivatives Instruments LossOnDerivativesInstruments	2108181	USD
	cvm	Loss On Derivatives Instruments LossOnDerivativesInstruments	2282518	USD
	cvm	Modification Of Warrant ModificationOfWarrant	192	USD
	cvm	Modification Of Warrant ModificationOfWarrant	0	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	0	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	476	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	680490	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	96951	USD
	cvm	Supplies Used For Rd And Manufacturing SuppliesUsedForRDAndManufacturing	-638771	USD
	cvm	Supplies Used For Rd And Manufacturing SuppliesUsedForRDAndManufacturing	-67185	USD
	cvm	Short Term Deposits ShortTermDeposits	-48210	USD
	cvm	Short Term Deposits ShortTermDeposits	0	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	123920	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-765872	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-142744	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	20110	USD
	us-gaap	Increase Decrease In Due To Officers And Stockholders IncreaseDecreaseInDueToOfficersAndStockholders	9083	USD
	us-gaap	Increase Decrease In Due To Officers And Stockholders IncreaseDecreaseInDueToOfficersAndStockholders	-34034	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	20793	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3438	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8784495	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7990218	USD
	cvm	Purchases Of Short Term Investments PurchasesOfShortTermInvestments	11145667	USD
	cvm	Purchases Of Short Term Investments PurchasesOfShortTermInvestments	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6629050	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17774717	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13559500	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	195295	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	184990	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2119170	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	-481773	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	-389132	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14642107	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-9077575	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5885096	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15508909	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8444774	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6431334	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14329870	USD
	cvm	Property Plant Equipment Included In Current Liabilities PropertyPlantEquipmentIncludedInCurrentLiabilities	1529284	USD
	cvm	Property Plant Equipment Included In Current Liabilities PropertyPlantEquipmentIncludedInCurrentLiabilities	318894	USD
	cvm	Capitalizable Patent Costs Included In Current Liabilities CapitalizablePatentCostsIncludedInCurrentLiabilities	20000	USD
	cvm	Capitalizable Patent Costs Included In Current Liabilities CapitalizablePatentCostsIncludedInCurrentLiabilities	13465	USD
	cvm	Changes To Right Of Use Assets And Liabilities ChangesToRightOfUseAssetsAndLiabilities	-139862	USD
	cvm	Changes To Right Of Use Assets And Liabilities ChangesToRightOfUseAssetsAndLiabilities	13712	USD
	cvm	Finance Lease Obligation Included In Accounts Payable FinanceLeaseObligationIncludedInAccountsPayable	1304	USD
	cvm	Finance Lease Obligation Included In Accounts Payable FinanceLeaseObligationIncludedInAccountsPayable	983	USD
	cvm	Prepaid Consulting Services Paid With Issuance Of Common Stock PrepaidConsultingServicesPaidWithIssuanceOfCommonStock	483960	USD
	cvm	Prepaid Consulting Services Paid With Issuance Of Common Stock PrepaidConsultingServicesPaidWithIssuanceOfCommonStock	137244	USD
	cvm	Accrued Consulting Services To Be Paid With Issuance Of Common Stock AccruedConsultingServicesToBePaidWithIssuanceOfCommonStock	165000	USD
	cvm	Accrued Consulting Services To Be Paid With Issuance Of Common Stock AccruedConsultingServicesToBePaidWithIssuanceOfCommonStock	165000	USD
	cvm	Fair Value Of Warrants Liabilities On Date Of Exercise FairValueOfWarrantsLiabilitiesOnDateOfExercise	3591185	USD
	cvm	Fair Value Of Warrants Liabilities On Date Of Exercise FairValueOfWarrantsLiabilitiesOnDateOfExercise	2546535	USD
	cvm	Financing Costs Included In Current Liabilities FinancingCostsIncludedInCurrentLiabilities	-13947	USD
	cvm	Financing Costs Included In Current Liabilities FinancingCostsIncludedInCurrentLiabilities	116549	USD
	us-gaap	Interest Paid Net InterestPaidNet	561445	USD
	us-gaap	Interest Paid Net InterestPaidNet	585748	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	20480	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	42165	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	67	shares
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"><em>Derivative Instruments</em> – The Company has financing arrangements that consist of freestanding derivative instruments that contain embedded derivative features. The Company accounts for these arrangements in accordance with Accounting Standards Codification (ASC) 815, “Accounting for Derivative Instruments and Hedging Activities.” In accordance with accounting principles generally accepted in the United States (U.S. GAAP), derivative instruments and hybrid instruments are recognized as either assets or liabilities in the balance sheet and are measured at fair value with gains or losses recognized in earnings or other comprehensive income depending on the nature of the derivative or hybrid instruments. The Company determines the fair value of derivative instruments and hybrid instruments based on available market data using appropriate valuation models considering all the rights and obligations of each instrument. The derivative liabilities are re-measured at fair value at the end of each interim reporting period. </p>
	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">B.<span style="font:7pt times new roman"> </span><span style="text-decoration:underline">OPERATIONS AND FINANCING</span> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">On May 4, 2020, the Company announced that the pivotal Phase 3 head and neck cancer study of Multikine immunotherapy had reached the targeted threshold of 298 events (deaths) required to conduct the data evaluation. Database lock has been completed and the Phase 3 study is now in the final statistical analysis phase. The Company will continue to remain blinded to the study results throughout this process. The Company will be advised of the results when the analysis is completed, and the study results will be announced to the public at that time.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">The Company has incurred significant costs since its inception for the acquisition of certain proprietary technology and scientific knowledge relating to the human immunological defense system, patent applications, research and development, administrative costs, construction of laboratory facilities and clinical trials. The Company has funded such costs primarily with proceeds from loans and the public and private sale of its securities. The Company will be required to raise additional capital or find additional long-term financing to continue with its research efforts. The ability to raise capital may be dependent upon market conditions that are outside the control of the Company. The ability of the Company to complete the necessary clinical trials and obtain FDA approval for the sale of products to be developed on a commercial basis is uncertain. Ultimately, the Company must complete the development of its products, obtain the appropriate regulatory approvals and obtain sufficient revenues to support its cost structure. The Company believes there is a high likelihood that it will continue to receive funds from private and public offerings and warrant exercises similar to the way it has substantially funded operations for the past 12 months. However, there can be no assurance that the Company will be able to raise sufficient capital to support its operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">To finance the Company, Management plans to raise additional capital in the form of warrant exercises, corporate partnerships, and debt and/or equity financings. The Company believes that it will be able to obtain additional financing because it has done so consistently in the past and because the Multikine Phase 3 study has ended and is only awaiting final data readout. However, there can be no assurance that the Company will be successful in raising additional funds on a timely basis or that the funds will be available to the Company on acceptable terms or at all. If the Company does not raise the necessary amounts of money, it may have to curtail its operations until it is able to raise the required funding. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"><em>Impact of COVID-19 Pandemic</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">In response to the global outbreak of COVID-19 and the World Health Organization’s classification of the outbreak as a pandemic, the Company continues to take the necessary precautions to ensure the safety of its employees and to minimize interruptions to its operations. Management follows the Centers for Disease Control and Prevention’s (“CDC”) guidance and the recommendations and restrictions provided by state and local authorities. The full impact of the COVID-19 outbreak continues to evolve as of the date of this report. As such, it is uncertain as to the full magnitude of impact the pandemic will have on the Company’s financial condition, liquidity and future results of operations. Management is actively monitoring the risks to public health and the impact of overall global business activity on its financial condition, liquidity, operations, suppliers, industry, and workforce.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">The financial statements have been prepared assuming the Company will continue as a going concern, but due to the Company’s recurring losses from operations and future liquidity needs, there is substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p>
	cvm	Schedule Stock Options Stock Bonuses And Compensation Granted By Company ScheduleStockOptionsStockBonusesAndCompensationGrantedByCompany	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Name of Plan</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total Shares Reserved <br/>Under Plans</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares Reserved for Outstanding Options</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares <br/>Issued</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining Options/Shares </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Under Plans</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Incentive Stock Options Plans</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">138,400</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">85,895</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">213</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Non-Qualified Stock Option Plans</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9,987,200</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,479,430</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,200,326</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock Bonus Plans</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">783,760</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">352,007</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">431,720</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock Compensation Plans</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">634,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150,695</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">464,895</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Incentive Stock Bonus Plan</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">640,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">614,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">25,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	8000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2500	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	54145	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1168	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	500	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1500	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	48845	shares
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	20480	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	12	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1132	shares
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	6579051	USD
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3581204	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	552664	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	347227	USD
CY2021Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3282742	USD
CY2020Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1780979	USD
CY2021Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	304004	USD
CY2020Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	191487	USD
CY2021Q1	cvm	Securities Purchase Agreements Amount Realized Through Resale Of Shares SecuritiesPurchaseAgreementsAmountRealizedThroughResaleOfShares	553630	USD
CY2021Q1	cvm	Fair Value Of Series Aa Warrants FairValueOfSeriesAaWarrants	619033	USD
CY2020Q3	cvm	Fair Value Of Series Aa Warrants FairValueOfSeriesAaWarrants	1082212	USD
CY2021Q1	cvm	Fair Value Of Series Bb Warrants FairValueOfSeriesBbWarrants	81374	USD
CY2020Q3	cvm	Fair Value Of Series Bb Warrants FairValueOfSeriesBbWarrants	65173	USD
CY2021Q1	cvm	Fair Value Of Series Cc Warrants FairValueOfSeriesCcWarrants	488784	USD
CY2020Q3	cvm	Fair Value Of Series Cc Warrants FairValueOfSeriesCcWarrants	1259712	USD
CY2021Q1	cvm	Fair Value Of Series Hh Warrants FairValueOfSeriesHhWarrants	2444	USD
	cvm	Schedule Of Derivative Liabilities Warrants And Other Options ScheduleOfDerivativeLiabilitiesWarrantsAndOtherOptions	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Warrant/Options</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Issue Date</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares Issuable upon Exercise </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>of Warrants/ Options</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Expiration Date</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td/><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Reference</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series N</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">8/18/2008</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">85,339</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.00</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">8/18/2021 </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series UU</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6/11/2018</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">93,603</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.80</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6/30/2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series X</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1/13/2016</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">120,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">9.25</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">7/13/2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series Y</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2/15/2016</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">26,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">12.00</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">8/15/2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series ZZ</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:15%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5/23/2016</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,200</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13.75</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:15%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5/18/2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">1</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series BB</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">8/26/2016</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">16,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">13.75</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">8/22/2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series Z</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5/23/2016</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">184,800</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">13.75</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">11/23/2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">1</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series FF</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/8/2016</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">68,048</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.91</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/1/2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series CC</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/8/2016</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">46,345</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">5.00</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/8/2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">1</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series HH</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2/23/2017</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">200</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.13</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2/16/2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">*</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series AA</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">8/26/2016</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">100,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">13.75</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2/22/2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">1</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series MM</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6/22/2017</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">481,361</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1.86</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6/22/2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series NN</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">7/24/2017</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">327,008</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.52</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">7/24/2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series RR</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">10/30/2017</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">347,560</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1.65</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">10/30/2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series SS</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/19/2017</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">220,800</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.09</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12/18/2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series TT</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2/5/2018</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">161,082</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.24</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2/5/2023</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Consultants</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">7/28/2017 – 11/18/2020</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">15,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td>$</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.18 - $11.61</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">11/17/2022 - 7/27/2027</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
	cvm	Schedule Of Derivative Liabilities At Fair Value ScheduleOfDerivativeLiabilitiesAtFairValue	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series W warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">73,570</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series Z warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,013,400</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,207,902</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series ZZ warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">77,574</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">75,044</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series AA warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">619,033</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,082,212</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series BB warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">81,374</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">65,173</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series CC warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">488,784</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,259,712</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series HH warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,444</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total warrant liabilities </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2,282,609</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">3,765,613</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021Q1	cvm	Fair Value Of Series W Warrants FairValueOfSeriesWWarrants	0	USD
CY2020Q3	cvm	Fair Value Of Series W Warrants FairValueOfSeriesWWarrants	73570	USD
CY2021Q1	cvm	Fair Value Of Series Zwarrants FairValueOfSeriesZwarrants	1013400	USD
CY2020Q3	cvm	Fair Value Of Series Zwarrants FairValueOfSeriesZwarrants	1207902	USD
CY2021Q1	cvm	Fair Value Of Series Zz Warrants FairValueOfSeriesZzWarrants	77574	USD
CY2020Q3	cvm	Fair Value Of Series Zz Warrants FairValueOfSeriesZzWarrants	75044	USD
CY2020Q3	cvm	Fair Value Of Series Hh Warrants FairValueOfSeriesHhWarrants	2000	USD
CY2021Q1	cvm	Total Fair Value Of Derivative Liabilities TotalFairValueOfDerivativeLiabilities	2282609	USD
CY2020Q3	cvm	Total Fair Value Of Derivative Liabilities TotalFairValueOfDerivativeLiabilities	3765613	USD
	cvm	Schedule Of Gains And Losses On Derivative Liabilities Table Textblock ScheduleOfGainsAndLossesOnDerivativeLiabilitiesTableTextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series V warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">78,461</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series W warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">73,570</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(367,369</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series Z warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(696,498</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(311,876</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series ZZ warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(11,530</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(4,585</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series AA warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(661,821</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(326,623</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series BB warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(16,201</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(7,028</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series CC warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(795,257</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(826,277</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series FF warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(319,706</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series HH warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(444</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(34,457</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series JJ warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(64,992</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Series LL warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(98,066</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Net loss on warrant liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">(2,108,181</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">(2,282,518</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series V warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(476,570</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series W warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(518,743</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series Z warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(974,861</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(322,425</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series ZZ warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(63,397</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(19,432</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series AA warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(995,629</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(391,601</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series BB warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(46,833</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6,597</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series CC warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(959,602</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(803,596</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series FF warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(312,517</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series HH warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(695</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(34,375</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series JJ warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(64,862</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Series LL warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(98,309</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Net loss on warrant liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">(3,041,017</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">(3,049,027</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table>
	cvm	Gain Loss Series V Warrants GainLossSeriesVWarrants	0	USD
	cvm	Gain Loss Series V Warrants GainLossSeriesVWarrants	78461	USD
	cvm	Gain Loss Series W Warrants GainLossSeriesWWarrants	73570	USD
	cvm	Gain Loss Series W Warrants GainLossSeriesWWarrants	367369	USD
	cvm	Gain Loss Series Z Warrants GainLossSeriesZWarrants	696498	USD
	cvm	Gain Loss Series Z Warrants GainLossSeriesZWarrants	311876	USD
	cvm	Gain Loss Series Zz Warrants GainLossSeriesZzWarrants	11530	USD
	cvm	Gain Loss Series Zz Warrants GainLossSeriesZzWarrants	4585	USD
	cvm	Gain Loss Series Aa Warrants GainLossSeriesAaWarrants	661821	USD
	cvm	Gain Loss Series Aa Warrants GainLossSeriesAaWarrants	326623	USD
	cvm	Gain Loss Series Bb Warrants GainLossSeriesBbWarrants	16201	USD
	cvm	Gain Loss Series Bb Warrants GainLossSeriesBbWarrants	7028	USD
	cvm	Gain Loss Series Cc Warrants GainLossSeriesCcWarrants	795257	USD
	cvm	Gain Loss Series Cc Warrants GainLossSeriesCcWarrants	826277	USD
	cvm	Gain Loss Series Ff Warrants GainLossSeriesFfWarrants	0	USD
	cvm	Gain Loss Series Ff Warrants GainLossSeriesFfWarrants	319706	USD
	cvm	Gain Loss Series Hh Warrants GainLossSeriesHhWarrants	444	USD
	cvm	Gain Loss Series Hh Warrants GainLossSeriesHhWarrants	34457	USD
	cvm	Gain Loss Series Jj Warrants GainLossSeriesJjWarrants	0	USD
	cvm	Gain Loss Series Jj Warrants GainLossSeriesJjWarrants	64992	USD
	cvm	Gain Loss Series Ll Warrants GainLossSeriesLlWarrants	0	USD
	cvm	Gain Loss Series Ll Warrants GainLossSeriesLlWarrants	98066	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	2108181	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	2282518	USD
CY2021Q1	cvm	Gain Loss Series V Warrants GainLossSeriesVWarrants	0	USD
CY2020Q1	cvm	Gain Loss Series V Warrants GainLossSeriesVWarrants	476570	USD
CY2021Q1	cvm	Gain Loss Series W Warrants GainLossSeriesWWarrants	0	USD
CY2020Q1	cvm	Gain Loss Series W Warrants GainLossSeriesWWarrants	518743	USD
CY2021Q1	cvm	Gain Loss Series Z Warrants GainLossSeriesZWarrants	974861	USD
CY2020Q1	cvm	Gain Loss Series Z Warrants GainLossSeriesZWarrants	322425	USD
CY2021Q1	cvm	Gain Loss Series Zz Warrants GainLossSeriesZzWarrants	63397	USD
CY2020Q1	cvm	Gain Loss Series Zz Warrants GainLossSeriesZzWarrants	19432	USD
CY2021Q1	cvm	Gain Loss Series Aa Warrants GainLossSeriesAaWarrants	995629	USD
CY2020Q1	cvm	Gain Loss Series Aa Warrants GainLossSeriesAaWarrants	391601	USD
CY2021Q1	cvm	Gain Loss Series Bb Warrants GainLossSeriesBbWarrants	46833	USD
CY2020Q1	cvm	Gain Loss Series Bb Warrants GainLossSeriesBbWarrants	6597	USD
CY2021Q1	cvm	Gain Loss Series Cc Warrants GainLossSeriesCcWarrants	959602	USD
CY2020Q1	cvm	Gain Loss Series Cc Warrants GainLossSeriesCcWarrants	803596	USD
CY2021Q1	cvm	Gain Loss Series Ff Warrants GainLossSeriesFfWarrants	0	USD
CY2020Q1	cvm	Gain Loss Series Ff Warrants GainLossSeriesFfWarrants	312517	USD
CY2021Q1	cvm	Gain Loss Series Hh Warrants GainLossSeriesHhWarrants	695	USD
CY2020Q1	cvm	Gain Loss Series Hh Warrants GainLossSeriesHhWarrants	34375	USD
CY2021Q1	cvm	Gain Loss Series Jj Warrants GainLossSeriesJjWarrants	0	USD
CY2020Q1	cvm	Gain Loss Series Jj Warrants GainLossSeriesJjWarrants	64862	USD
CY2021Q1	cvm	Gain Loss Series Ll Warrants GainLossSeriesLlWarrants	0	USD
CY2020Q1	cvm	Gain Loss Series Ll Warrants GainLossSeriesLlWarrants	98309	USD
CY2021Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	3041017	USD
CY2020Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	3049027	USD
CY2021Q1	cvm	Warrants Exercised WarrantsExercised	277298	shares
CY2021Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2961490	USD
	cvm	Warrants Exercised WarrantsExercised	282298	shares
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2986490	USD
	cvm	Warrants Exercised WarrantsExercised	234016	shares
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1028997	USD
CY2020Q1	cvm	Warrants Exercised WarrantsExercised	234016	shares
CY2020Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1028997	USD
CY2021Q1	cvm	Equity Warrants Exercised EquityWarrantsExercised	713941	shares
CY2021Q1	cvm	Proceeds From Equity Warrant Exercises ProceedsFromEquityWarrantExercises	1428016	USD
	cvm	Equity Warrants Exercised EquityWarrantsExercised	723941	shares
	cvm	Proceeds From Equity Warrant Exercises ProceedsFromEquityWarrantExercises	1450416	USD
CY2020Q1	cvm	Equity Warrants Exercised EquityWarrantsExercised	328084	shares
CY2020Q1	cvm	Proceeds From Equity Warrant Exercises ProceedsFromEquityWarrantExercises	743174	USD
	cvm	Equity Warrants Exercised EquityWarrantsExercised	460984	shares
	cvm	Proceeds From Equity Warrant Exercises ProceedsFromEquityWarrantExercises	1040275	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	28000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.65
	cvm	Fttdd fttdd	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Six Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>3/31/2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>3/31/2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>3/31/2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>3/31/2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amount realized through the resale of shares</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">675,236</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,720,680</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">553,630</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">934,511</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
	cvm	Securities Purchase Agreements Amount Realized Through Resale Of Shares SecuritiesPurchaseAgreementsAmountRealizedThroughResaleOfShares	675236	USD
	cvm	Securities Purchase Agreements Amount Realized Through Resale Of Shares SecuritiesPurchaseAgreementsAmountRealizedThroughResaleOfShares	1720680	USD
CY2021Q1	cvm	Net Present Value Of Lease Finance Lease Obligations NetPresentValueOfLeaseFinanceLeaseObligations	12066000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	18254000	USD
CY2021Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	-6188000	USD
CY2020Q1	cvm	Securities Purchase Agreements Amount Realized Through Resale Of Shares SecuritiesPurchaseAgreementsAmountRealizedThroughResaleOfShares	934511	USD
	us-gaap	Unrealized Gain On Securities UnrealizedGainOnSecurities	7000	USD
	cvm	Weighted Average Interest Rate WeightedAverageInterestRate	0.0009	pure
CY2020Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3765613	USD
CY2018Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6488310	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	0	USD
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-3591185	USD
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-3071775	USD
	cvm	Fair Value Measured On Recurring Basis Gain Loss Included Earnings FairValueMeasuredOnRecurringBasisGainLossIncludedEarnings	2108181	USD
CY2019	cvm	Fair Value Measured On Recurring Basis Gain Loss Included Earnings FairValueMeasuredOnRecurringBasisGainLossIncludedEarnings	349078	USD
CY2019Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3765613	USD
	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	86000	USD
	cvm	Clinical Service Trial ClinicalServiceTrial	12000000	USD
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	34500000	USD
	cvm	Net Of Discount NetOfDiscount	11400000	USD
CY2021Q1	cvm	Finance Lease Right Of Use Assets FinanceLeaseRightOfUseAssets	12800000	USD
CY2020Q3	cvm	Finance Lease Right Of Use Assets FinanceLeaseRightOfUseAssets	13800000	USD
CY2021Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	12100000	USD
CY2020Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	12700000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	900000	USD
	cvm	Cash Paid Related To Finance Leases CashPaidRelatedToFinanceLeases	1000000.0	USD
	cvm	Cash Paid Related To Finance Leases Interest CashPaidRelatedToFinanceLeasesInterest	600000	USD
CY2021Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.100	pure
	cvm	Maturity Years MaturityYears	P7Y7M6D
CY2021Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1700000	USD
CY2021Q1	cvm	Net Book Value Operating Lease Right Of Use Assets NetBookValueOperatingLeaseRightOfUseAssets	1100000	USD
CY2020Q3	cvm	Net Book Value Operating Lease Right Of Use Assets NetBookValueOperatingLeaseRightOfUseAssets	1200000	USD
CY2021Q1	cvm	Finance Lease Liability Payments Due Remainder Of Year FinanceLeaseLiabilityPaymentsDueRemainderOfYear	-1192000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2486000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2569000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	2648000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	2733000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	2824000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	6186000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1200000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1300000	USD
CY2021Q1	cvm	Finance Lease Obligations Net Of Current Portion FinanceLeaseObligationsNetOfCurrentPortion	200000	USD
CY2020Q3	cvm	Finance Lease Obligations Net Of Current Portion FinanceLeaseObligationsNetOfCurrentPortion	100000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	132000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	135000	USD
CY2021Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	66000	USD
CY2020Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	68000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	111000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	132000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	63000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	66000	USD
CY2021Q1	cvm	Lessee Operating Lease Liability Payments Due Remainder Of Year LesseeOperatingLeaseLiabilityPaymentsDueRemainderOfYear	129000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	264000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	272000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	280000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	288000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	207000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	80000	USD
CY2021Q1	cvm	Lessee Operating Lease Liability Payments LesseeOperatingLeaseLiabilityPayments	1520000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	-327000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1193000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	27000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	26000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	48000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	38000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	31000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	28000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	24000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	97000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	292000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6247564	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6771443	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19303763	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9089552	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39351194	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35621711	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40047273	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36165050	shares
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.49
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.41
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25

us-gaap

Earnings Per Share Basic And Diluted

EarningsPerShareBasicAndDiluted

-0.49

us-gaap

Earnings Per Share Basic And Diluted

EarningsPerShareBasicAndDiluted

-0.41

CY2021Q2

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

40906593

shares

CY2020Q3

us-gaap

Short Term Investments

ShortTermInvestments

0

USD

CY2020Q3

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

54922

USD

CY2020Q3

us-gaap

Prepaid Expense Current

PrepaidExpenseCurrent

1313432

USD

CY2021Q1

us-gaap

Inventory Net

InventoryNet

1458823

USD

CY2020Q3

us-gaap

Inventory Net

InventoryNet

820052

USD

CY2021Q1

us-gaap

Deposits Assets Current

DepositsAssetsCurrent

48210

USD

CY2020Q3

us-gaap

Deposit Assets

DepositAssets

1670917

USD

CY2021Q1

us-gaap

Assets

48365171

USD

CY2020Q3

us-gaap

Assets

40536454

USD

CY2021Q1

us-gaap

Accounts Payable Current

AccountsPayableCurrent

2391316

USD

CY2020Q3

us-gaap

Accounts Payable Current

AccountsPayableCurrent

2023067

USD

CY2021Q1

us-gaap

Accrued Liabilities Current

AccruedLiabilitiesCurrent

519071

USD

CY2020Q3

us-gaap

Accrued Liabilities Current

AccruedLiabilitiesCurrent

510515

USD

CY2020Q3

us-gaap

Deposits Assets Current

DepositsAssetsCurrent

0

USD

CY2021Q1

us-gaap

Assets Current

AssetsCurrent

19866689

USD

CY2021Q1

us-gaap

Due To Officers Or Stockholders Current

DueToOfficersOrStockholdersCurrent

457105

USD

CY2020Q3

us-gaap

Due To Officers Or Stockholders Current

DueToOfficersOrStockholdersCurrent

448022

USD

CY2021Q1

us-gaap

Derivative Liabilities Current

DerivativeLiabilitiesCurrent

2282609

USD

CY2020Q3

us-gaap

Derivative Liabilities Current

DerivativeLiabilitiesCurrent

213787

USD

CY2020Q3

us-gaap

Assets Current

AssetsCurrent

17697315

USD

CY2021Q1

us-gaap

Finance Lease Right Of Use Asset

FinanceLeaseRightOfUseAsset

12814612

USD

CY2020Q3

us-gaap

Finance Lease Right Of Use Asset

FinanceLeaseRightOfUseAsset

13811849

USD

CY2021Q1

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

1121029

USD

CY2020Q3

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

1198958

USD

CY2021Q1

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

12599492

USD

CY2020Q3

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

5843993

USD

CY2021Q1

us-gaap

Finite Lived Patents Gross

FiniteLivedPatentsGross

292432

USD

CY2020Q3

us-gaap

Finite Lived Patents Gross

FiniteLivedPatentsGross

313422

USD

CY2021Q1

us-gaap

Deposit Assets

DepositAssets

1670917

USD

CY2021Q1

cvm

Lease Liabilities Current Portion

LeaseLiabilitiesCurrentPortion

172454

USD

CY2020Q3

cvm

Lease Liabilities Current Portion

LeaseLiabilitiesCurrentPortion

1070123

USD

CY2021Q1

us-gaap

Liabilities Current

LiabilitiesCurrent

5822555

USD

CY2020Q3

us-gaap

Liabilities Current

LiabilitiesCurrent

4265514

USD

CY2021Q1

us-gaap

Derivative Liabilities Noncurrent

DerivativeLiabilitiesNoncurrent

0

USD

CY2020Q3

us-gaap

Derivative Liabilities Noncurrent

DerivativeLiabilitiesNoncurrent

3551826

USD

CY2021Q1

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

12054543

USD

CY2020Q3

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

11753100

USD

CY2021Q1

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

1031281

USD

CY2020Q3

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

1114340

USD

CY2021Q1

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

125000

USD

CY2020Q3

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

125000

USD

CY2021Q1

us-gaap

Liabilities

19033379

USD

CY2020Q3

us-gaap

Liabilities

20809780

USD

CY2021Q1

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

0

USD

CY2021Q1

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.01

CY2021Q1

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

200000

shares

CY2021Q1

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

0

shares

CY2021Q1

us-gaap

Preferred Stock Value

PreferredStockValue

0

USD

CY2020Q3

us-gaap

Preferred Stock Value

PreferredStockValue

0

USD

CY2021Q1

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2021Q1

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

600000000

shares

CY2021Q1

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

40823975

shares

CY2020Q3

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

38730150

shares

CY2021Q1

us-gaap

Common Stock Value

CommonStockValue

408240

USD

CY2020Q3

us-gaap

Common Stock Value

CommonStockValue

387302

USD

CY2021Q1

us-gaap

Additional Paid In Capital

AdditionalPaidInCapital

429976839

USD

CY2020Q3

us-gaap

Additional Paid In Capital

AdditionalPaidInCapital

401174675

USD

CY2021Q1

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-401053287

USD

CY2020Q3

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-381835303

USD

CY2021Q1

us-gaap

Stockholders Equity

StockholdersEquity

29331792

USD

CY2020Q3

us-gaap

Stockholders Equity

StockholdersEquity

19726674

USD

CY2021Q1

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

48365171

USD

CY2020Q3

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

40536454

USD

us-gaap

Other Income

OtherIncome

0

USD

us-gaap

Other Income

OtherIncome

334232

USD

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

10636274

USD

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

8711360

USD

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

6627640

USD

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

5197418

USD

us-gaap

Operating Expenses

OperatingExpenses

17263914

USD

us-gaap

Operating Expenses

OperatingExpenses

13908778

USD

us-gaap

Operating Income Loss

OperatingIncomeLoss

-17263914

USD

us-gaap

Operating Income Loss

OperatingIncomeLoss

-13574546

USD

us-gaap

Other Nonoperating Income

OtherNonoperatingIncome

0

USD

us-gaap

Other Nonoperating Income

OtherNonoperatingIncome

36896

USD

cvm

Gain Loss On Derivatives Instruments

GainLossOnDerivativesInstruments

-2108181

USD

cvm

Gain Loss On Derivatives Instruments

GainLossOnDerivativesInstruments

-2282518

USD

us-gaap

Other Nonoperating Gains Losses

OtherNonoperatingGainsLosses

675236

USD

us-gaap

Other Nonoperating Gains Losses

OtherNonoperatingGainsLosses

1725180

USD

us-gaap

Interest Income Expense Net

InterestIncomeExpenseNet

-504190

USD

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-19217984

USD

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-14599178

USD

cvm

Modification Of Warrants

ModificationOfWarrants

-85779

USD

cvm

Modification Of Warrants

ModificationOfWarrants

-21734

USD

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

-19303763

USD

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

-14620912

USD

us-gaap

Weighted Average Number Of Share Outstanding Basic And Diluted

WeightedAverageNumberOfShareOutstandingBasicAndDiluted

39351194

shares

us-gaap

Weighted Average Number Of Share Outstanding Basic And Diluted

WeightedAverageNumberOfShareOutstandingBasicAndDiluted

35621711

shares

CY2021Q1

us-gaap

Other Income

OtherIncome

0

USD

CY2020Q1

us-gaap

Other Income

OtherIncome

298726

USD

CY2021Q1

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

5221514

USD

CY2020Q1

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

4458547

USD

CY2021Q1

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

3311484

USD

CY2020Q1

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

2558522

USD

CY2021Q1

us-gaap

Operating Expenses

OperatingExpenses

8532998

USD

CY2020Q1

us-gaap

Operating Expenses

OperatingExpenses

7017069

USD

CY2021Q1

us-gaap

Operating Income Loss

OperatingIncomeLoss

-8532998

USD

CY2020Q1

us-gaap

Operating Income Loss

OperatingIncomeLoss

-6718343

USD

CY2021Q1

us-gaap

Other Nonoperating Income

OtherNonoperatingIncome

0

USD

CY2020Q1

us-gaap

Other Nonoperating Income

OtherNonoperatingIncome

18448

USD

CY2021Q1

cvm

Gain Loss On Derivatives Instruments

GainLossOnDerivativesInstruments

-3041017

USD

CY2020Q1

cvm

Gain Loss On Derivatives Instruments

GainLossOnDerivativesInstruments

-3049027

USD

CY2021Q1

us-gaap

Other Nonoperating Gains Losses

OtherNonoperatingGainsLosses

553630

USD

CY2020Q1

us-gaap

Other Nonoperating Gains Losses

OtherNonoperatingGainsLosses

934511

USD

CY2021Q1

us-gaap

Interest Income Expense Net

InterestIncomeExpenseNet

-260735

USD

CY2020Q1

us-gaap

Interest Income Expense Net

InterestIncomeExpenseNet

-253407

USD

CY2021Q1

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-11281120

USD

CY2020Q1

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-9067818

USD

CY2021Q1

cvm

Modification Of Warrants

ModificationOfWarrants

0

USD

CY2020Q1

cvm

Modification Of Warrants

ModificationOfWarrants

-21734

USD

CY2021Q1

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

-11281120

USD

CY2020Q1

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

-9089552

USD

CY2021Q1

us-gaap

Earnings Per Share Basic And Diluted

EarningsPerShareBasicAndDiluted

-0.28

CY2020Q1

us-gaap

Earnings Per Share Basic And Diluted

EarningsPerShareBasicAndDiluted

-0.25

CY2021Q1

us-gaap

Weighted Average Number Of Share Outstanding Basic And Diluted

WeightedAverageNumberOfShareOutstandingBasicAndDiluted

40047273

shares

CY2020Q1

us-gaap

Weighted Average Number Of Share Outstanding Basic And Diluted

WeightedAverageNumberOfShareOutstandingBasicAndDiluted

36165050

shares

CY2020Q4

cvm

Proceeds From The Sale Of Common Stock Amount

ProceedsFromTheSaleOfCommonStockAmount

13559500

USD

CY2020Q4

cvm

Warrant Exercises Amount

WarrantExercisesAmount

89250

USD

CY2020Q4

cvm

Equity Based Compensation Employees Amount

EquityBasedCompensationEmployeesAmount

3296309

USD

CY2020Q4

cvm

Contributionspai Incommonstock Amount

ContributionspaiIncommonstockAmount

41671

USD

CY2020Q4

us-gaap

Stock Issued During Period Value Issued For Services

StockIssuedDuringPeriodValueIssuedForServices

152450

USD

CY2020Q4

cvm

Options Exercises Amount

OptionsExercisesAmount

23511

USD

CY2020Q4

cvm

Modification Of Warrants Amount

ModificationOfWarrantsAmount

192

USD

CY2020Q4

cvm

Share Issuance Costs

ShareIssuanceCosts

-117021

USD

CY2020Q4

us-gaap

Net Income Loss

NetIncomeLoss

-7936864

USD

CY2020Q4

us-gaap

Stockholders Equity

StockholdersEquity

28835672

USD

CY2021Q1

cvm

Warrant Exercises Amount

WarrantExercisesAmount

7938841

USD

CY2021Q1

cvm

Equity Based Compensation Employees Amount

EquityBasedCompensationEmployeesAmount

3282742

USD

CY2021Q1

cvm

Contributions Paid In Common Stock Amount

ContributionsPaidInCommonStockAmount

51420

USD

CY2021Q1

us-gaap

Stock Issued During Period Value Issued For Services

StockIssuedDuringPeriodValueIssuedForServices

379277

USD

CY2021Q1

cvm

Options Exercises Amount

OptionsExercisesAmount

138788

USD

CY2021Q1

cvm

Share Issuance Costs

ShareIssuanceCosts

-13828

USD

CY2021Q1

us-gaap

Net Income Loss

NetIncomeLoss

-11281120

USD

CY2021Q1

us-gaap

Stockholders Equity

StockholdersEquity

29331792

USD

CY2019Q4

cvm

Adoption Of New Accounting Standard

AdoptionOfNewAccountingStandard

2146195

USD

CY2019Q4

us-gaap

Stock Issued During Period Value New Issues

StockIssuedDuringPeriodValueNewIssues

5050003

USD

CY2019Q4

cvm

Warrant Exercises Amount

WarrantExercisesAmount

297101

USD

CY2019Q4

cvm

Equity Based Compensation Employees Amount

EquityBasedCompensationEmployeesAmount

1800225

USD

CY2019Q4

cvm

Contributions Paid In Common Stock Amount

ContributionsPaidInCommonStockAmount

40937

USD

cvm

Short Term Investment

ShortTermInvestment

5728

USD

cvm

Short Term Investment

ShortTermInvestment

0

USD

CY2019Q3

us-gaap

Stockholders Equity

StockholdersEquity

5133667

USD

CY2019Q4

us-gaap

Stock Issued During Period Value Issued For Services

StockIssuedDuringPeriodValueIssuedForServices

84447

USD

CY2019Q4

us-gaap

Stock Issued During Period Value Other

StockIssuedDuringPeriodValueOther

25000

USD

CY2019Q4

cvm

Share Issuance Costs

ShareIssuanceCosts

-92150

USD

CY2019Q4

us-gaap

Net Income Loss

NetIncomeLoss

-5531360

USD

CY2019Q4

us-gaap

Stockholders Equity

StockholdersEquity

8954065

USD

CY2020Q1

cvm

Proceeds From The Sale Of Common Stock Amount

ProceedsFromTheSaleOfCommonStockAmount

7867629

USD

CY2020Q1

cvm

Warrant Exercises Amount

WarrantExercisesAmount

4318706

USD

CY2020Q1

cvm

Equity Based Compensation Employees Amount

EquityBasedCompensationEmployeesAmount

1780979

USD

CY2020Q1

cvm

Contributions Paid In Common Stock Amount

ContributionsPaidInCommonStockAmount

38959

USD

CY2020Q1

us-gaap

Stock Issued During Period Value Issued For Services

StockIssuedDuringPeriodValueIssuedForServices

235024

USD

CY2020Q1

cvm

Purchase Of Stock By Officers And Directors Amount

PurchaseOfStockByOfficersAndDirectorsAmount

159990

USD

CY2020Q1

cvm

Options Exercises Amount

OptionsExercisesAmount

49898

USD

CY2020Q1

cvm

Share Issuance Costs

ShareIssuanceCosts

-199372

USD

CY2020Q1

us-gaap

Net Income Loss

NetIncomeLoss

-9067818

USD

CY2020Q1

us-gaap

Stockholders Equity

StockholdersEquity

14138060

USD

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-19217984

USD

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-14599178

USD

us-gaap

Depreciation And Amortization

DepreciationAndAmortization

1101477

USD

us-gaap

Depreciation And Amortization

DepreciationAndAmortization

1064231

USD

us-gaap

Issuance Of Stock And Warrants For Services Or Claims

IssuanceOfStockAndWarrantsForServicesOrClaims

552664

USD

us-gaap

Issuance Of Stock And Warrants For Services Or Claims

IssuanceOfStockAndWarrantsForServicesOrClaims

347227

USD

us-gaap

Share Based Compensation

ShareBasedCompensation

6579051

USD

us-gaap

Share Based Compensation

ShareBasedCompensation

3581204

USD

cvm

Common Stock Contributed To Employee Benefit Plan

CommonStockContributedToEmployeeBenefitPlan

93091

USD

cvm

Common Stock Contributed To Employee Benefit Plan

CommonStockContributedToEmployeeBenefitPlan

79896

USD

cvm

Loss On Derivatives Instruments

LossOnDerivativesInstruments

2108181

USD

cvm

Loss On Derivatives Instruments

LossOnDerivativesInstruments

2282518

USD

cvm

Modification Of Warrant

ModificationOfWarrant

192

USD

cvm

Modification Of Warrant

ModificationOfWarrant

0

USD

us-gaap

Increase Decrease In Receivables

IncreaseDecreaseInReceivables

0

USD

us-gaap

Increase Decrease In Receivables

IncreaseDecreaseInReceivables

476

USD

us-gaap

Increase Decrease In Prepaid Expense

IncreaseDecreaseInPrepaidExpense

680490

USD

us-gaap

Increase Decrease In Prepaid Expense

IncreaseDecreaseInPrepaidExpense

96951

USD

cvm

Supplies Used For Rd And Manufacturing

SuppliesUsedForRDAndManufacturing

-638771

USD

cvm

Supplies Used For Rd And Manufacturing

SuppliesUsedForRDAndManufacturing

-67185

USD

cvm

Short Term Deposits

ShortTermDeposits

-48210

USD

cvm

Short Term Deposits

ShortTermDeposits

0

USD

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

123920

USD

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

-765872

USD

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

-142744

USD

us-gaap

Increase Decrease In Accrued Liabilities

IncreaseDecreaseInAccruedLiabilities

20110

USD

us-gaap

Increase Decrease In Due To Officers And Stockholders

IncreaseDecreaseInDueToOfficersAndStockholders

9083

USD

us-gaap

Increase Decrease In Due To Officers And Stockholders

IncreaseDecreaseInDueToOfficersAndStockholders

-34034

USD

us-gaap

Increase Decrease In Other Operating Liabilities

IncreaseDecreaseInOtherOperatingLiabilities

20793

USD

us-gaap

Increase Decrease In Other Operating Liabilities

IncreaseDecreaseInOtherOperatingLiabilities

3438

USD

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

-8784495

USD

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

-7990218

USD

cvm

Purchases Of Short Term Investments

PurchasesOfShortTermInvestments

11145667

USD

cvm

Purchases Of Short Term Investments

PurchasesOfShortTermInvestments

0

USD

us-gaap

Payments To Acquire Property Plant And Equipment

PaymentsToAcquirePropertyPlantAndEquipment

6629050

USD

us-gaap

Payments To Acquire Intangible Assets

PaymentsToAcquireIntangibleAssets

0

USD

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-17774717

USD

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

13559500

USD

us-gaap

Payments Of Stock Issuance Costs

PaymentsOfStockIssuanceCosts

195295

USD

us-gaap

Proceeds From Issuance Or Sale Of Equity

ProceedsFromIssuanceOrSaleOfEquity

0

USD

us-gaap

Proceeds From Issuance Or Sale Of Equity

ProceedsFromIssuanceOrSaleOfEquity

184990

USD

us-gaap

Proceeds From Warrant Exercises

ProceedsFromWarrantExercises

2119170

USD

us-gaap

Finance Lease Principal Payments

FinanceLeasePrincipalPayments

-481773

USD

us-gaap

Finance Lease Principal Payments

FinanceLeasePrincipalPayments

-389132

USD

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

14642107

USD

us-gaap

Cash And Cash Equivalents Period Increase Decrease

CashAndCashEquivalentsPeriodIncreaseDecrease

-9077575

USD

us-gaap

Cash And Cash Equivalents Period Increase Decrease

CashAndCashEquivalentsPeriodIncreaseDecrease

5885096

USD

CY2020Q3

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

15508909

USD

CY2019Q3

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

8444774

USD

CY2021Q1

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

6431334

USD

CY2020Q1

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

14329870

USD

cvm

Property Plant Equipment Included In Current Liabilities

PropertyPlantEquipmentIncludedInCurrentLiabilities

1529284

USD

cvm

Property Plant Equipment Included In Current Liabilities

PropertyPlantEquipmentIncludedInCurrentLiabilities

318894

USD

cvm

Capitalizable Patent Costs Included In Current Liabilities

CapitalizablePatentCostsIncludedInCurrentLiabilities

20000

USD

cvm

Capitalizable Patent Costs Included In Current Liabilities

CapitalizablePatentCostsIncludedInCurrentLiabilities

13465

USD

cvm

Changes To Right Of Use Assets And Liabilities

ChangesToRightOfUseAssetsAndLiabilities

-139862

USD

cvm

Changes To Right Of Use Assets And Liabilities

ChangesToRightOfUseAssetsAndLiabilities

13712

USD

cvm

Finance Lease Obligation Included In Accounts Payable

FinanceLeaseObligationIncludedInAccountsPayable

1304

USD

cvm

Finance Lease Obligation Included In Accounts Payable

FinanceLeaseObligationIncludedInAccountsPayable

983

USD

cvm

Prepaid Consulting Services Paid With Issuance Of Common Stock

PrepaidConsultingServicesPaidWithIssuanceOfCommonStock

483960

USD

cvm

Prepaid Consulting Services Paid With Issuance Of Common Stock

PrepaidConsultingServicesPaidWithIssuanceOfCommonStock

137244

USD

cvm

Accrued Consulting Services To Be Paid With Issuance Of Common Stock

AccruedConsultingServicesToBePaidWithIssuanceOfCommonStock

165000

USD

cvm

Accrued Consulting Services To Be Paid With Issuance Of Common Stock

AccruedConsultingServicesToBePaidWithIssuanceOfCommonStock

165000

USD

cvm

Fair Value Of Warrants Liabilities On Date Of Exercise

FairValueOfWarrantsLiabilitiesOnDateOfExercise

3591185

USD

cvm

Fair Value Of Warrants Liabilities On Date Of Exercise

FairValueOfWarrantsLiabilitiesOnDateOfExercise

2546535

USD

cvm

Financing Costs Included In Current Liabilities

FinancingCostsIncludedInCurrentLiabilities

-13947

USD

cvm

Financing Costs Included In Current Liabilities

FinancingCostsIncludedInCurrentLiabilities

116549

USD

us-gaap

Interest Paid Net

InterestPaidNet

561445

USD

us-gaap

Interest Paid Net

InterestPaidNet

585748

USD

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

20480

shares

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

42165

shares

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

1000

shares

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

67

shares

us-gaap

Derivatives Reporting Of Derivative Activity

DerivativesReportingOfDerivativeActivity

Derivative Instruments – The Company has financing arrangements that consist of freestanding derivative instruments that contain embedded derivative features. The Company accounts for these arrangements in accordance with Accounting Standards Codification (ASC) 815, “Accounting for Derivative Instruments and Hedging Activities.” In accordance with accounting principles generally accepted in the United States (U.S. GAAP), derivative instruments and hybrid instruments are recognized as either assets or liabilities in the balance sheet and are measured at fair value with gains or losses recognized in earnings or other comprehensive income depending on the nature of the derivative or hybrid instruments. The Company determines the fair value of derivative instruments and hybrid instruments based on available market data using appropriate valuation models considering all the rights and obligations of each instrument. The derivative liabilities are re-measured at fair value at the end of each interim reporting period.

us-gaap

Nature Of Operations

NatureOfOperations

B. OPERATIONS AND FINANCING On May 4, 2020, the Company announced that the pivotal Phase 3 head and neck cancer study of Multikine immunotherapy had reached the targeted threshold of 298 events (deaths) required to conduct the data evaluation. Database lock has been completed and the Phase 3 study is now in the final statistical analysis phase. The Company will continue to remain blinded to the study results throughout this process. The Company will be advised of the results when the analysis is completed, and the study results will be announced to the public at that time. The Company has incurred significant costs since its inception for the acquisition of certain proprietary technology and scientific knowledge relating to the human immunological defense system, patent applications, research and development, administrative costs, construction of laboratory facilities and clinical trials. The Company has funded such costs primarily with proceeds from loans and the public and private sale of its securities. The Company will be required to raise additional capital or find additional long-term financing to continue with its research efforts. The ability to raise capital may be dependent upon market conditions that are outside the control of the Company. The ability of the Company to complete the necessary clinical trials and obtain FDA approval for the sale of products to be developed on a commercial basis is uncertain. Ultimately, the Company must complete the development of its products, obtain the appropriate regulatory approvals and obtain sufficient revenues to support its cost structure. The Company believes there is a high likelihood that it will continue to receive funds from private and public offerings and warrant exercises similar to the way it has substantially funded operations for the past 12 months. However, there can be no assurance that the Company will be able to raise sufficient capital to support its operations. To finance the Company, Management plans to raise additional capital in the form of warrant exercises, corporate partnerships, and debt and/or equity financings. The Company believes that it will be able to obtain additional financing because it has done so consistently in the past and because the Multikine Phase 3 study has ended and is only awaiting final data readout. However, there can be no assurance that the Company will be successful in raising additional funds on a timely basis or that the funds will be available to the Company on acceptable terms or at all. If the Company does not raise the necessary amounts of money, it may have to curtail its operations until it is able to raise the required funding. Impact of COVID-19 Pandemic In response to the global outbreak of COVID-19 and the World Health Organization’s classification of the outbreak as a pandemic, the Company continues to take the necessary precautions to ensure the safety of its employees and to minimize interruptions to its operations. Management follows the Centers for Disease Control and Prevention’s (“CDC”) guidance and the recommendations and restrictions provided by state and local authorities. The full impact of the COVID-19 outbreak continues to evolve as of the date of this report. As such, it is uncertain as to the full magnitude of impact the pandemic will have on the Company’s financial condition, liquidity and future results of operations. Management is actively monitoring the risks to public health and the impact of overall global business activity on its financial condition, liquidity, operations, suppliers, industry, and workforce. The financial statements have been prepared assuming the Company will continue as a going concern, but due to the Company’s recurring losses from operations and future liquidity needs, there is substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

cvm

Schedule Stock Options Stock Bonuses And Compensation Granted By Company

ScheduleStockOptionsStockBonusesAndCompensationGrantedByCompany

<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;">Name of Plan</td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;">Total Shares Reserved Under Plans</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;">Shares Reserved for Outstanding Options</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;">Shares Issued</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;">Remaining Options/Shares Under Plans</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Incentive Stock Options Plans</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">138,400</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">85,895</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">213</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Non-Qualified Stock Option Plans</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9,987,200</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,479,430</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,200,326</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Stock Bonus Plans</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">783,760</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">352,007</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">431,720</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Stock Compensation Plans</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">634,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">150,695</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">464,895</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Incentive Stock Bonus Plan</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">640,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">614,500</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">25,500</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table>

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

8000

shares

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

2500

shares

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

54145

shares

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

1168

shares

CY2021Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

500

shares

CY2020Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

1500

shares

CY2021Q1

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

48845

shares

CY2020Q1

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

20480

shares

CY2020Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

1000

shares

CY2021Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

12

shares

CY2020Q1

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

1132

shares

us-gaap

Employee Benefits And Share Based Compensation

EmployeeBenefitsAndShareBasedCompensation

6579051

USD

us-gaap

Employee Benefits And Share Based Compensation

EmployeeBenefitsAndShareBasedCompensation

3581204

USD

us-gaap

Issuance Of Stock And Warrants For Services Or Claims

IssuanceOfStockAndWarrantsForServicesOrClaims

552664

USD

us-gaap

Issuance Of Stock And Warrants For Services Or Claims

IssuanceOfStockAndWarrantsForServicesOrClaims

347227

USD

CY2021Q1

us-gaap

Employee Benefits And Share Based Compensation

EmployeeBenefitsAndShareBasedCompensation

3282742

USD

CY2020Q1

us-gaap

Employee Benefits And Share Based Compensation

EmployeeBenefitsAndShareBasedCompensation

1780979

USD

CY2021Q1

us-gaap

Issuance Of Stock And Warrants For Services Or Claims

IssuanceOfStockAndWarrantsForServicesOrClaims

304004

USD

CY2020Q1

us-gaap

Issuance Of Stock And Warrants For Services Or Claims

IssuanceOfStockAndWarrantsForServicesOrClaims

191487

USD

CY2021Q1

cvm

Securities Purchase Agreements Amount Realized Through Resale Of Shares

SecuritiesPurchaseAgreementsAmountRealizedThroughResaleOfShares

553630

USD

CY2021Q1

cvm

Fair Value Of Series Aa Warrants

FairValueOfSeriesAaWarrants

619033

USD

CY2020Q3

cvm

Fair Value Of Series Aa Warrants

FairValueOfSeriesAaWarrants

1082212

USD

CY2021Q1

cvm

Fair Value Of Series Bb Warrants

FairValueOfSeriesBbWarrants

81374

USD

CY2020Q3

cvm

Fair Value Of Series Bb Warrants

FairValueOfSeriesBbWarrants

65173

USD

CY2021Q1

cvm

Fair Value Of Series Cc Warrants

FairValueOfSeriesCcWarrants

488784

USD

CY2020Q3

cvm

Fair Value Of Series Cc Warrants

FairValueOfSeriesCcWarrants

1259712

USD

CY2021Q1

cvm

Fair Value Of Series Hh Warrants

FairValueOfSeriesHhWarrants

2444

USD

cvm

Schedule Of Derivative Liabilities Warrants And Other Options

ScheduleOfDerivativeLiabilitiesWarrantsAndOtherOptions

<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;">Warrant/Options</td><td style="white-space: nowrap;"> </td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;">Issue Date</td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;">Shares Issuable upon Exercise of Warrants/ Options</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;">Exercise Price</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;">Expiration Date</td><td style="white-space: nowrap;"> </td><td/><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;">Reference</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series N</td><td style="white-space: nowrap;"> </td><td>8/18/2008</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">85,339</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.00</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>8/18/2021 </td><td style="white-space: nowrap;"> </td><td/><td>*</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series UU</td><td style="white-space: nowrap;"> </td><td>6/11/2018</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">93,603</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.80</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>6/30/2021</td><td style="white-space: nowrap;"> </td><td/><td>*</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series X</td><td style="white-space: nowrap;"> </td><td>1/13/2016</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">120,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">9.25</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>7/13/2021</td><td style="white-space: nowrap;"> </td><td/><td>*</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series Y</td><td style="white-space: nowrap;"> </td><td>2/15/2016</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">26,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">12.00</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>8/15/2021</td><td style="white-space: nowrap;"> </td><td/><td>*</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series ZZ</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:15%;">5/23/2016</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,200</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13.75</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:15%;">5/18/2021</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series BB</td><td style="white-space: nowrap;"> </td><td>8/26/2016</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">16,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">13.75</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>8/22/2021</td><td style="white-space: nowrap;"> </td><td/><td>*</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series Z</td><td style="white-space: nowrap;"> </td><td>5/23/2016</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">184,800</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">13.75</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>11/23/2021</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series FF</td><td style="white-space: nowrap;"> </td><td>12/8/2016</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">68,048</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.91</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>12/1/2021</td><td style="white-space: nowrap;"> </td><td/><td>*</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series CC</td><td style="white-space: nowrap;"> </td><td>12/8/2016</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">46,345</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">5.00</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>12/8/2021</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series HH</td><td style="white-space: nowrap;"> </td><td>2/23/2017</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">200</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.13</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>2/16/2022</td><td style="white-space: nowrap;"> </td><td/><td>*</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series AA</td><td style="white-space: nowrap;"> </td><td>8/26/2016</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">100,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">13.75</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>2/22/2022</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series MM</td><td style="white-space: nowrap;"> </td><td>6/22/2017</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">481,361</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1.86</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>6/22/2022</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series NN</td><td style="white-space: nowrap;"> </td><td>7/24/2017</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">327,008</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.52</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>7/24/2022</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series RR</td><td style="white-space: nowrap;"> </td><td>10/30/2017</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">347,560</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1.65</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>10/30/2022</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series SS</td><td style="white-space: nowrap;"> </td><td>12/19/2017</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">220,800</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.09</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>12/18/2022</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series TT</td><td style="white-space: nowrap;"> </td><td>2/5/2018</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">161,082</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2.24</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>2/5/2023</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Consultants</td><td style="white-space: nowrap;"> </td><td>7/28/2017 – 11/18/2020</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">15,000</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>$</td><td>2.18 - $11.61</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td>11/17/2022 - 7/27/2027</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3</td><td style="white-space: nowrap;"> </td></tr></tbody></table>

cvm

Schedule Of Derivative Liabilities At Fair Value

ScheduleOfDerivativeLiabilitiesAtFairValue

<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;">March 31,2021</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;">September 30, 2020</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series W warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">73,570</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series Z warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,013,400</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,207,902</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series ZZ warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">77,574</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">75,044</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series AA warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">619,033</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,082,212</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series BB warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">81,374</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">65,173</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series CC warrants</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">488,784</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,259,712</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series HH warrants</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,444</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Total warrant liabilities </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2,282,609</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">3,765,613</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td></tr></tbody></table>

CY2021Q1

cvm

Fair Value Of Series W Warrants

FairValueOfSeriesWWarrants

0

USD

CY2020Q3

cvm

Fair Value Of Series W Warrants

FairValueOfSeriesWWarrants

73570

USD

CY2021Q1

cvm

Fair Value Of Series Zwarrants

FairValueOfSeriesZwarrants

1013400

USD

CY2020Q3

cvm

Fair Value Of Series Zwarrants

FairValueOfSeriesZwarrants

1207902

USD

CY2021Q1

cvm

Fair Value Of Series Zz Warrants

FairValueOfSeriesZzWarrants

77574

USD

CY2020Q3

cvm

Fair Value Of Series Zz Warrants

FairValueOfSeriesZzWarrants

75044

USD

CY2020Q3

cvm

Fair Value Of Series Hh Warrants

FairValueOfSeriesHhWarrants

2000

USD

CY2021Q1

cvm

Total Fair Value Of Derivative Liabilities

TotalFairValueOfDerivativeLiabilities

2282609

USD

CY2020Q3

cvm

Total Fair Value Of Derivative Liabilities

TotalFairValueOfDerivativeLiabilities

3765613

USD

cvm

Schedule Of Gains And Losses On Derivative Liabilities Table Textblock

ScheduleOfGainsAndLossesOnDerivativeLiabilitiesTableTextblock

<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series V warrants</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">78,461</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series W warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">73,570</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(367,369</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series Z warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(696,498</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(311,876</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series ZZ warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(11,530</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(4,585</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series AA warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(661,821</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(326,623</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series BB warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(16,201</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(7,028</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series CC warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(795,257</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(826,277</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series FF warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(319,706</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series HH warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(444</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(34,457</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series JJ warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(64,992</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series LL warrants</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(98,066</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Net loss on warrant liabilities</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">(2,108,181</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">(2,282,518</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series V warrants</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(476,570</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series W warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(518,743</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series Z warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(974,861</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(322,425</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series ZZ warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(63,397</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(19,432</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series AA warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(995,629</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(391,601</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series BB warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(46,833</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(6,597</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series CC warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(959,602</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(803,596</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series FF warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(312,517</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series HH warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(695</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(34,375</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Series JJ warrants </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(64,862</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Series LL warrants</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(98,309</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Net loss on warrant liabilities</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">(3,041,017</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">(3,049,027</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table>

cvm

Gain Loss Series V Warrants

GainLossSeriesVWarrants

0

USD

cvm

Gain Loss Series V Warrants

GainLossSeriesVWarrants

78461

USD

cvm

Gain Loss Series W Warrants

GainLossSeriesWWarrants

73570

USD

cvm

Gain Loss Series W Warrants

GainLossSeriesWWarrants

367369

USD

cvm

Gain Loss Series Z Warrants

GainLossSeriesZWarrants

696498

USD

cvm

Gain Loss Series Z Warrants

GainLossSeriesZWarrants

311876

USD

cvm

Gain Loss Series Zz Warrants

GainLossSeriesZzWarrants

11530

USD

cvm

Gain Loss Series Zz Warrants

GainLossSeriesZzWarrants

4585

USD

cvm

Gain Loss Series Aa Warrants

GainLossSeriesAaWarrants

661821

USD

cvm

Gain Loss Series Aa Warrants

GainLossSeriesAaWarrants

326623

USD

cvm

Gain Loss Series Bb Warrants

GainLossSeriesBbWarrants

16201

USD

cvm

Gain Loss Series Bb Warrants

GainLossSeriesBbWarrants

7028

USD

cvm

Gain Loss Series Cc Warrants

GainLossSeriesCcWarrants

795257

USD

cvm

Gain Loss Series Cc Warrants

GainLossSeriesCcWarrants

826277

USD

cvm

Gain Loss Series Ff Warrants

GainLossSeriesFfWarrants

0

USD

cvm

Gain Loss Series Ff Warrants

GainLossSeriesFfWarrants

319706

USD

cvm

Gain Loss Series Hh Warrants

GainLossSeriesHhWarrants

444

USD

cvm

Gain Loss Series Hh Warrants

GainLossSeriesHhWarrants

34457

USD

cvm

Gain Loss Series Jj Warrants

GainLossSeriesJjWarrants

0

USD

cvm

Gain Loss Series Jj Warrants

GainLossSeriesJjWarrants

64992

USD

cvm

Gain Loss Series Ll Warrants

GainLossSeriesLlWarrants

0

USD

cvm

Gain Loss Series Ll Warrants

GainLossSeriesLlWarrants

98066

USD

us-gaap

Gain Loss On Derivative Instruments Net Pretax

GainLossOnDerivativeInstrumentsNetPretax

2108181

USD

us-gaap

Gain Loss On Derivative Instruments Net Pretax

GainLossOnDerivativeInstrumentsNetPretax

2282518

USD

CY2021Q1

cvm

Gain Loss Series V Warrants

GainLossSeriesVWarrants

0

USD

CY2020Q1

cvm

Gain Loss Series V Warrants

GainLossSeriesVWarrants

476570

USD

CY2021Q1

cvm

Gain Loss Series W Warrants

GainLossSeriesWWarrants

0

USD

CY2020Q1

cvm

Gain Loss Series W Warrants

GainLossSeriesWWarrants

518743

USD

CY2021Q1

cvm

Gain Loss Series Z Warrants

GainLossSeriesZWarrants

974861

USD

CY2020Q1

cvm

Gain Loss Series Z Warrants

GainLossSeriesZWarrants

322425

USD

CY2021Q1

cvm

Gain Loss Series Zz Warrants

GainLossSeriesZzWarrants

63397

USD

CY2020Q1

cvm

Gain Loss Series Zz Warrants

GainLossSeriesZzWarrants

19432

USD

CY2021Q1

cvm

Gain Loss Series Aa Warrants

GainLossSeriesAaWarrants

995629

USD

CY2020Q1

cvm

Gain Loss Series Aa Warrants

GainLossSeriesAaWarrants

391601

USD

CY2021Q1

cvm

Gain Loss Series Bb Warrants

GainLossSeriesBbWarrants

46833

USD

CY2020Q1

cvm

Gain Loss Series Bb Warrants

GainLossSeriesBbWarrants

6597

USD

CY2021Q1

cvm

Gain Loss Series Cc Warrants

GainLossSeriesCcWarrants

959602

USD

CY2020Q1

cvm

Gain Loss Series Cc Warrants

GainLossSeriesCcWarrants

803596

USD

CY2021Q1

cvm

Gain Loss Series Ff Warrants

GainLossSeriesFfWarrants

0

USD

CY2020Q1

cvm

Gain Loss Series Ff Warrants

GainLossSeriesFfWarrants

312517

USD

CY2021Q1

cvm

Gain Loss Series Hh Warrants

GainLossSeriesHhWarrants

695

USD

CY2020Q1

cvm

Gain Loss Series Hh Warrants

GainLossSeriesHhWarrants

34375

USD

CY2021Q1

cvm

Gain Loss Series Jj Warrants

GainLossSeriesJjWarrants

0

USD

CY2020Q1

cvm

Gain Loss Series Jj Warrants

GainLossSeriesJjWarrants

64862

USD

CY2021Q1

cvm

Gain Loss Series Ll Warrants

GainLossSeriesLlWarrants

0

USD

CY2020Q1

cvm

Gain Loss Series Ll Warrants

GainLossSeriesLlWarrants

98309

USD

CY2021Q1

us-gaap

Gain Loss On Derivative Instruments Net Pretax

GainLossOnDerivativeInstrumentsNetPretax

3041017

USD

CY2020Q1

us-gaap

Gain Loss On Derivative Instruments Net Pretax

GainLossOnDerivativeInstrumentsNetPretax

3049027

USD

CY2021Q1

cvm

Warrants Exercised

WarrantsExercised

277298

shares

CY2021Q1

us-gaap

Proceeds From Issuance Of Warrants

ProceedsFromIssuanceOfWarrants

2961490

USD

cvm

Warrants Exercised

WarrantsExercised

282298

shares

us-gaap

Proceeds From Issuance Of Warrants

ProceedsFromIssuanceOfWarrants

2986490

USD

cvm

Warrants Exercised

WarrantsExercised

234016

shares

us-gaap

Proceeds From Issuance Of Warrants

ProceedsFromIssuanceOfWarrants

1028997

USD

CY2020Q1

cvm

Warrants Exercised

WarrantsExercised

234016

shares

CY2020Q1

us-gaap

Proceeds From Issuance Of Warrants

ProceedsFromIssuanceOfWarrants

1028997

USD

CY2021Q1

cvm

Equity Warrants Exercised

EquityWarrantsExercised

713941

shares

CY2021Q1

cvm

Proceeds From Equity Warrant Exercises

ProceedsFromEquityWarrantExercises

1428016

USD

cvm

Equity Warrants Exercised

EquityWarrantsExercised

723941

shares

cvm

Proceeds From Equity Warrant Exercises

ProceedsFromEquityWarrantExercises

1450416

USD

CY2020Q1

cvm

Equity Warrants Exercised

EquityWarrantsExercised

328084

shares

CY2020Q1

cvm

Proceeds From Equity Warrant Exercises

ProceedsFromEquityWarrantExercises

743174

USD

cvm

Equity Warrants Exercised

EquityWarrantsExercised

460984

shares

cvm

Proceeds From Equity Warrant Exercises

ProceedsFromEquityWarrantExercises

1040275

USD

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1

28000

USD

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

5.65

cvm

Fttdd

fttdd

<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Six Months Ended</td><td style="white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">Three Months Ended</td><td style="white-space: nowrap;"> </td></tr><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">3/31/2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">3/31/2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">3/31/2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;">3/31/2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Amount realized through the resale of shares</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">675,236</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,720,680</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">553,630</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">934,511</td><td style="width:1%;white-space: nowrap;"> </td></tr></tbody></table>

cvm

Securities Purchase Agreements Amount Realized Through Resale Of Shares

SecuritiesPurchaseAgreementsAmountRealizedThroughResaleOfShares

675236

USD

cvm

Securities Purchase Agreements Amount Realized Through Resale Of Shares

SecuritiesPurchaseAgreementsAmountRealizedThroughResaleOfShares

1720680

USD

CY2021Q1

cvm

Net Present Value Of Lease Finance Lease Obligations

NetPresentValueOfLeaseFinanceLeaseObligations

12066000

USD

CY2021Q1

us-gaap

Finance Lease Liability Payments Due

FinanceLeaseLiabilityPaymentsDue

18254000

USD

CY2021Q1

us-gaap

Finance Lease Liability Undiscounted Excess Amount

FinanceLeaseLiabilityUndiscountedExcessAmount

-6188000

USD

CY2020Q1

cvm

Securities Purchase Agreements Amount Realized Through Resale Of Shares

SecuritiesPurchaseAgreementsAmountRealizedThroughResaleOfShares

934511

USD

us-gaap

Unrealized Gain On Securities

UnrealizedGainOnSecurities

7000

USD

cvm

Weighted Average Interest Rate

WeightedAverageInterestRate

0.0009

pure

CY2020Q3

us-gaap

Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value

FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue

3765613

USD

CY2018Q3

us-gaap

Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value

FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue

6488310

USD

us-gaap

Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues

FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues

0

USD

CY2019

us-gaap

Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues

FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues

0

USD

us-gaap

Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales

FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales

-3591185

USD

CY2019

us-gaap

Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales

FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales

-3071775

USD

cvm

Fair Value Measured On Recurring Basis Gain Loss Included Earnings

FairValueMeasuredOnRecurringBasisGainLossIncludedEarnings

2108181

USD

CY2019

cvm

Fair Value Measured On Recurring Basis Gain Loss Included Earnings

FairValueMeasuredOnRecurringBasisGainLossIncludedEarnings

349078

USD

CY2019Q3

us-gaap

Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value

FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue

3765613

USD

us-gaap

Other Interest And Dividend Income

OtherInterestAndDividendIncome

86000

USD

cvm

Clinical Service Trial

ClinicalServiceTrial

12000000

USD

us-gaap

Other Research And Development Expense

OtherResearchAndDevelopmentExpense

34500000

USD

cvm

Net Of Discount

NetOfDiscount

11400000

USD

CY2021Q1

cvm

Finance Lease Right Of Use Assets

FinanceLeaseRightOfUseAssets

12800000

USD

CY2020Q3

cvm

Finance Lease Right Of Use Assets

FinanceLeaseRightOfUseAssets

13800000

USD

CY2021Q1

us-gaap

Finance Lease Liability

FinanceLeaseLiability

12100000

USD

CY2020Q3

us-gaap

Finance Lease Liability

FinanceLeaseLiability

12700000

USD

CY2020Q3

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

900000

USD

cvm

Cash Paid Related To Finance Leases

CashPaidRelatedToFinanceLeases

1000000.0

USD

cvm

Cash Paid Related To Finance Leases Interest

CashPaidRelatedToFinanceLeasesInterest

600000

USD

CY2021Q1

us-gaap

Finance Lease Weighted Average Discount Rate Percent

FinanceLeaseWeightedAverageDiscountRatePercent

0.100

pure

cvm

Maturity Years

MaturityYears

P7Y7M6D

CY2021Q1

us-gaap

Assets Noncurrent

AssetsNoncurrent

1700000

USD

CY2021Q1

cvm

Net Book Value Operating Lease Right Of Use Assets

NetBookValueOperatingLeaseRightOfUseAssets

1100000

USD

CY2020Q3

cvm

Net Book Value Operating Lease Right Of Use Assets

NetBookValueOperatingLeaseRightOfUseAssets

1200000

USD

CY2021Q1

cvm

Finance Lease Liability Payments Due Remainder Of Year

FinanceLeaseLiabilityPaymentsDueRemainderOfYear

-1192000

USD

CY2021Q1

us-gaap

Finance Lease Liability Payments Due Next Twelve Months

FinanceLeaseLiabilityPaymentsDueNextTwelveMonths

2486000

USD

CY2021Q1

us-gaap

Finance Lease Liability Payments Due Year Two

FinanceLeaseLiabilityPaymentsDueYearTwo

2569000

USD

CY2021Q1

us-gaap

Finance Lease Liability Payments Due Year Three

FinanceLeaseLiabilityPaymentsDueYearThree

2648000

USD

CY2021Q1

us-gaap

Finance Lease Liability Payments Due Year Four

FinanceLeaseLiabilityPaymentsDueYearFour

2733000

USD

CY2021Q1

us-gaap

Finance Lease Liability Payments Due Year Five

FinanceLeaseLiabilityPaymentsDueYearFive

2824000

USD

CY2021Q1

us-gaap

Finance Lease Liability Payments Due After Year Five

FinanceLeaseLiabilityPaymentsDueAfterYearFive

6186000

USD

CY2021Q1

us-gaap

Operating Lease Liability

OperatingLeaseLiability

1200000

USD

CY2020Q3

us-gaap

Operating Lease Liability

OperatingLeaseLiability

1300000

USD

CY2021Q1

cvm

Finance Lease Obligations Net Of Current Portion

FinanceLeaseObligationsNetOfCurrentPortion

200000

USD

CY2020Q3

cvm

Finance Lease Obligations Net Of Current Portion

FinanceLeaseObligationsNetOfCurrentPortion

100000

USD

us-gaap

Lease And Rental Expense

LeaseAndRentalExpense

132000

USD

us-gaap

Lease And Rental Expense

LeaseAndRentalExpense

135000

USD

CY2021Q1

us-gaap

Lease And Rental Expense

LeaseAndRentalExpense

66000

USD

CY2020Q1

us-gaap

Lease And Rental Expense

LeaseAndRentalExpense

68000

USD

us-gaap

Operating Lease Payments

OperatingLeasePayments

111000

USD

us-gaap

Operating Lease Payments

OperatingLeasePayments

132000

USD

CY2021Q1

us-gaap

Operating Lease Payments

OperatingLeasePayments

63000

USD

CY2020Q1

us-gaap

Operating Lease Payments

OperatingLeasePayments

66000

USD

CY2021Q1

cvm

Lessee Operating Lease Liability Payments Due Remainder Of Year

LesseeOperatingLeaseLiabilityPaymentsDueRemainderOfYear

129000

USD

CY2021Q1

us-gaap

Lessee Operating Lease Liability Payments Due Next Twelve Months

LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

264000

USD

CY2021Q1

us-gaap

Lessee Operating Lease Liability Payments Due Year Two

LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

272000

USD

CY2021Q1

us-gaap

Lessee Operating Lease Liability Payments Due Year Three

LesseeOperatingLeaseLiabilityPaymentsDueYearThree

280000

USD

CY2021Q1

us-gaap

Lessee Operating Lease Liability Payments Due Year Four

LesseeOperatingLeaseLiabilityPaymentsDueYearFour

288000

USD

CY2021Q1

us-gaap

Lessee Operating Lease Liability Payments Due Year Five

LesseeOperatingLeaseLiabilityPaymentsDueYearFive

207000

USD

CY2021Q1

us-gaap

Lessee Operating Lease Liability Payments Due After Year Five

LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

80000

USD

CY2021Q1

cvm

Lessee Operating Lease Liability Payments

LesseeOperatingLeaseLiabilityPayments

1520000

USD

CY2021Q1

us-gaap

Lessee Operating Lease Liability Undiscounted Excess Amount

LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

-327000

USD

CY2021Q1

us-gaap

Lessee Operating Lease Liability Payments Due

LesseeOperatingLeaseLiabilityPaymentsDue

1193000

USD

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

26000

USD

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

27000

USD

CY2021Q1

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

13000

USD

CY2020Q1

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

14000

USD

CY2021Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year

FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear

26000

USD

CY2021Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Next Twelve Months

FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

48000

USD

CY2021Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Two

FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

38000

USD

CY2021Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Three

FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

31000

USD

CY2021Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Four

FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

28000

USD

CY2021Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Five

FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

24000

USD

CY2021Q1

us-gaap

Finite Lived Intangible Assets Amortization Expense Rolling After Year Five

FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive

97000

USD

CY2021Q1

us-gaap

Finite Lived Intangible Assets Net

FiniteLivedIntangibleAssetsNet

292000

USD

us-gaap

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount

AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

6247564

shares

us-gaap

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount

AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

6771443

shares

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

-19303763

USD

CY2020Q1

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

-9089552

USD

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

39351194

shares

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

35621711

shares

CY2021Q1

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

40047273

shares

CY2020Q1

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

36165050

shares

us-gaap

Earnings Per Share Basic And Diluted

EarningsPerShareBasicAndDiluted

-0.49

us-gaap

Earnings Per Share Basic And Diluted

EarningsPerShareBasicAndDiluted

-0.41

CY2021Q1

us-gaap

Earnings Per Share Basic And Diluted

EarningsPerShareBasicAndDiluted

-0.28

CY2020Q1

us-gaap

Earnings Per Share Basic And Diluted

EarningsPerShareBasicAndDiluted

-0.25

Name	View Source	Status
0001654954-21-005882-index-headers.html	Edgar Link	pending
0001654954-21-005882-index.html	Edgar Link	pending
0001654954-21-005882.txt	Edgar Link	pending
0001654954-21-005882-xbrl.zip	Edgar Link	pending
cvm-20210331.xsd	Edgar Link	pending
cvm-20210331_cal.xml	Edgar Link	unprocessable
cvm-20210331_def.xml	Edgar Link	unprocessable
cvm-20210331_lab.xml	Edgar Link	unprocessable
cvm-20210331_pre.xml	Edgar Link	unprocessable
cvm_10q.htm	Edgar Link	pending
cvm_10q_htm.xml	Edgar Link	completed
cvm_ex31.htm	Edgar Link	pending
cvm_ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CVM
CEL SCI CORP Stock $cvm

2021 Q1 Form 10-Q Financial Statement

#000165495421005882 Filed on May 17, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVM CEL SCI CORP Stock $cvm

2021 Q1 Form 10-Q Financial Statement

#000165495421005882 Filed on May 17, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVM
CEL SCI CORP Stock $cvm